Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CABB Group is a leading global contract development and manufacturing organization (CDMO) and a major producer of high-purity reagents and intermediates. The company specializes in complex multi-step synthesis and is one of the world's largest manufacturers of monochloroacetic acid (MCAA), a vital precursor for the pharmaceutical and agrochemical industries. CABB provides comprehensive services including process optimization, pilot-scale production, and large-scale commercial manufacturing under stringent GMP conditions. Their expertise covers hazardous chemistry, such as chlorination and sulfonation, enabling the production of critical active ingredients and specialty chemicals. Headquartered in Germany, the group operates a global network of production sites across Europe, Asia, and North America to support its international clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CABB Group.